Zonisamide
- Product NDC
- 51407-137
- 11-digit product format
- 514070137
- Labeler code
- 51407
- Product ID
- 51407-137_f1daa508-7d38-806d-e053-2995a90a577a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zonisamide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA077634
- Marketing category
- ANDA
- Marketing start
- 2006-03-17
- Marketing end
- 2023-03-31
- Substance
- ZONISAMIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-137-01 | 51407013701 | 100 CAPSULE in 1 BOTTLE (51407-137-01) | 100 capsule | 2018-09-11 | 0000-00-00 | No | No | Current |